1. Home
  2. RBOT vs ADAG Comparison

RBOT vs ADAG Comparison

Compare RBOT & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBOT
  • ADAG
  • Stock Information
  • Founded
  • RBOT 2014
  • ADAG 2011
  • Country
  • RBOT United States
  • ADAG China
  • Employees
  • RBOT N/A
  • ADAG N/A
  • Industry
  • RBOT Medical Specialities
  • ADAG Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBOT Health Care
  • ADAG Health Care
  • Exchange
  • RBOT Nasdaq
  • ADAG Nasdaq
  • Market Cap
  • RBOT 88.6M
  • ADAG 81.9M
  • IPO Year
  • RBOT N/A
  • ADAG 2021
  • Fundamental
  • Price
  • RBOT $15.00
  • ADAG $1.76
  • Analyst Decision
  • RBOT Hold
  • ADAG Strong Buy
  • Analyst Count
  • RBOT 2
  • ADAG 1
  • Target Price
  • RBOT $10.25
  • ADAG $8.00
  • AVG Volume (30 Days)
  • RBOT 39.9K
  • ADAG 153.3K
  • Earning Date
  • RBOT 03-03-2025
  • ADAG 03-09-2025
  • Dividend Yield
  • RBOT N/A
  • ADAG N/A
  • EPS Growth
  • RBOT N/A
  • ADAG N/A
  • EPS
  • RBOT N/A
  • ADAG N/A
  • Revenue
  • RBOT N/A
  • ADAG $815,746.00
  • Revenue This Year
  • RBOT N/A
  • ADAG N/A
  • Revenue Next Year
  • RBOT N/A
  • ADAG $2.70
  • P/E Ratio
  • RBOT N/A
  • ADAG N/A
  • Revenue Growth
  • RBOT N/A
  • ADAG N/A
  • 52 Week Low
  • RBOT $4.27
  • ADAG $1.64
  • 52 Week High
  • RBOT $19.00
  • ADAG $3.65
  • Technical
  • Relative Strength Index (RSI)
  • RBOT 58.49
  • ADAG 42.36
  • Support Level
  • RBOT $11.73
  • ADAG $1.64
  • Resistance Level
  • RBOT $13.92
  • ADAG $1.95
  • Average True Range (ATR)
  • RBOT 1.06
  • ADAG 0.10
  • MACD
  • RBOT 0.10
  • ADAG 0.00
  • Stochastic Oscillator
  • RBOT 93.70
  • ADAG 37.50

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: